ÂÜÀòÂÒÂ×

Victoria Bartlett is Vice President, Alliance and Program Management at Verve Therapeutics. She has over 20 years of industry experience, predominantly in program, alliance, and portfolio management. Dr. Bartlett joins us from Ionis Pharmaceuticals, where she worked as senior director of alliance management and was responsible for the Ionis partnerships within the cardio-renal franchise. Prior to that, Dr. Bartlett was with Akcea Therapeutics, as senior director of program and alliance management, where she led the phase 2 clinical programs for three antisense oligonucleotide programs targeting Apo(a) (pelacarsen), ANGPTL3 (vupanorsen), and APOCIII. In addition, she held program, alliance, and portfolio positions at CRISPR Therapeutics, Moderna, Pfizer and Wyeth Research. Dr. Bartlett has both a Ph.D. and B.Sc. in Pharmacology from the University of Liverpool and she spent 4 years as a postdoctoral fellow at Harvard Medical School.